Literature DB >> 35306261

Regenerative Medicine Therapies for Prevention of Abdominal Adhesions: A Scoping Review.

Samuel P Carmichael1, Jaewook Shin2, John W Vaughan3, Prafulla K Chandra3, John B Holcomb4, Anthony J Atala3.   

Abstract

INTRODUCTION: Globally, abdominal adhesions constitute a significant burden of morbidity and mortality. They represent the commonest complication of abdominal operations with a lifelong risk of multiple pathologies, including adhesive small bowel obstruction, female infertility, and chronic pain. Adhesions represent a problem of the entire abdomen, forming at the time of injury and progressing through multiple complex pathways. Clinically available preventative strategies are limited to barrier technologies. Significant knowledge gaps persist in the characterization and mitigation of the involved molecular pathways underlying adhesion formation. Thus, the objectives of this scoping review are to describe the known molecular pathophysiology implicated in abdominal adhesion formation and summarize novel preclinical regenerative medicine preventative strategies for potential future clinical investigation.
METHODS: A literature review was performed in accordance with the Preferred Reporting Items for Systematic Reviews Extension for Scoping Reviews. Included peer-reviewed publications were published within the last 5 y and contained in vivo preclinical experimental studies of postoperative adhesions with the assessment of underlying mechanisms of adhesion formation and successful therapy for adhesion prevention. Studies not involving regenerative medicine strategies were excluded. Data were qualitatively synthesized.
RESULTS: A total of 1762 articles were identified. Of these, 1001 records were excluded by the described screening criteria. Sixty-eight full-text articles were evaluated for eligibility, and 11 studies were included for review.
CONCLUSIONS: Novel and reliable preventative strategies are urgently needed. Recent experimental data propose novel regenerative medicine targets for adhesion prevention.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Abdominal adhesions; Bowel obstruction; Fibrosis; Regenerative medicine; Small molecules; Stem cells

Mesh:

Year:  2022        PMID: 35306261      PMCID: PMC9038705          DOI: 10.1016/j.jss.2022.02.005

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.417


  90 in total

Review 1.  Amniotic fluid and placental membranes: unexpected sources of highly multipotent cells.

Authors:  Sean V Murphy; Anthony Atala
Journal:  Semin Reprod Med       Date:  2013-01-17       Impact factor: 1.303

2.  The SCAR-3 study: 5-year adhesion-related readmission risk following lower abdominal surgical procedures.

Authors:  M C Parker; M S Wilson; D Menzies; G Sunderland; D N Clark; A D Knight; A M Crowe
Journal:  Colorectal Dis       Date:  2005-11       Impact factor: 3.788

3.  Sodium hyaluronate-based bioresorbable membrane (Seprafilm) reduced early postoperative intestinal obstruction after lower abdominal surgery for colorectal cancer: the preliminary report.

Authors:  Chi-Min Park; Woo Yong Lee; Yong Beom Cho; Hae Ran Yun; Won-Suk Lee; Seong Hyeon Yun; Ho-Kyung Chun
Journal:  Int J Colorectal Dis       Date:  2008-10-25       Impact factor: 2.571

4.  Effect of hypoxia on gene expression of bone marrow-derived mesenchymal stem cells and mononuclear cells.

Authors:  Shunsuke Ohnishi; Takeshi Yasuda; Soichiro Kitamura; Noritoshi Nagaya
Journal:  Stem Cells       Date:  2007-02-08       Impact factor: 6.277

5.  Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition.

Authors:  Debra F Higgins; Kuniko Kimura; Wanja M Bernhardt; Nikita Shrimanker; Yasuhiro Akai; Bernd Hohenstein; Yoshihiko Saito; Randall S Johnson; Matthias Kretzler; Clemens D Cohen; Kai-Uwe Eckardt; Masayuki Iwano; Volker H Haase
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

Review 6.  Peritoneal adhesions: Occurrence, prevention and experimental models.

Authors:  Jingyi Tang; Ziyin Xiang; Matthew T Bernards; Shengfu Chen
Journal:  Acta Biomater       Date:  2020-08-29       Impact factor: 8.947

7.  c-Jun protects hypoxia-inducible factor-1alpha from degradation via its oxygen-dependent degradation domain in a nontranscriptional manner.

Authors:  Bing Yu; Ze-Hong Miao; Yi Jiang; Mei-Hong Li; Na Yang; Ting Li; Jian Ding
Journal:  Cancer Res       Date:  2009-09-08       Impact factor: 12.701

8.  Interferon γ and plasminogen activator inhibitor 1 regulate adhesion formation after partial hepatectomy.

Authors:  K Ohashi; T Yoshimoto; H Kosaka; T Hirano; Y Iimuro; K Nakanishi; J Fujimoto
Journal:  Br J Surg       Date:  2014-03       Impact factor: 6.939

9.  Risk factors in the development of stem cell therapy.

Authors:  Carla A Herberts; Marcel S G Kwa; Harm P H Hermsen
Journal:  J Transl Med       Date:  2011-03-22       Impact factor: 5.531

10.  Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-β1 signaling.

Authors:  Toshinori Ueno; Ayumu Nakashima; Shigehiro Doi; Takeshi Kawamoto; Kiyomasa Honda; Yukio Yokoyama; Toshiki Doi; Yukihito Higashi; Noriaki Yorioka; Yukio Kato; Nobuoki Kohno; Takao Masaki
Journal:  Kidney Int       Date:  2013-03-13       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.